Skip to content
Wenlo
Sign in
← Markets

Moderna Inc.

Stephen Hoge (President) sells MRNA shares

4MRNAFiled Oct 16, 2026, 4:09 PM ET· Period Oct 14, 2026

AI-generated summary

President Stephen Hoge exercised options for 152,905 shares of Common Stock for $1,866,970.05 and sold 78,369 shares of Common Stock for $17,013,537.68. Following these transactions, the insider directly held 1,636,565 shares. The transactions were executed under a Rule 10b5-1 trading plan adopted on June 15, 2026.

View original filing on SEC.gov (opens SEC EDGAR)

Key facts

Insider
Stephen Hoge · President

Rule 10b5-1 plan · adopted Jun 15, 2026

DateTransactionSharesPriceValueHeld afterOwnership
Oct 14, 2026M · exercise or conversion of a derivativeFootnotes F1+76,453$12.21$933,491.131,638,482Direct
Oct 14, 2026S · open-market saleFootnotes F1, F2−38,774$213.47$8,277,085.781,599,708Direct
Oct 14, 2026S · open-market saleFootnotes F1, F3−450$214.15$96,367.501,599,258Direct
Oct 15, 2026M · exercise or conversion of a derivativeFootnotes F1+76,452$12.21$933,478.921,675,710Direct
Oct 15, 2026S · open-market saleFootnotes F1, F4−39,145$220.72$8,640,084.401,636,565Direct
Oct 14, 2026M · exercise or conversion of a derivativeStock Option (Right to Buy)Footnotes F1, F6−76,453$0.00$0.00229,357Direct
Oct 15, 2026M · exercise or conversion of a derivativeStock Option (Right to Buy)Footnotes F1, F6−76,452$0.00$0.00152,905Direct
Footnotes
  1. F1 The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on June 15, 2026.
  2. F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $213.03 to $213.91. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  3. F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $214.05 to $214.37. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  4. F4 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $220.60 to $221.35. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  5. F5 These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
  6. F6 This option is fully vested and exercisable.

More MRNA filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.